Ares Commercial Real Estate (ACRE) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
14 Nov, 2025Executive summary
Reported GAAP net income of $5 million ($0.08 per diluted share) for Q3 2025, reversing a prior year loss, with distributable earnings of $6 million ($0.10 per diluted share) and $7 million ($0.13 per share) excluding realized losses.
Book value per share was $9.47 at quarter-end, with a declared Q4 dividend of $0.15 per share (annualized yield ~14%).
Sequential earnings growth, stable CECL reserves, and consistent book value per share were achieved while reducing net debt-to-equity ratio.
Over $360 million in new loan commitments since the start of Q3, with $271 million closed after quarter-end.
Nearly $500 million in repayments collected year-to-date, enhancing liquidity.
Financial highlights
Net interest margin for Q3 2025 was $8.5 million, with total revenue of $14.1 million and interest income of $23.3 million.
Available capital stood at $173 million, including $88 million in cash as of September 30, 2025.
Outstanding borrowings reduced to $811 million, down 9% quarter-over-quarter and 40% year-over-year.
Loans held for investment at September 30, 2025: $1.23 billion carrying amount, $1.29 billion principal.
Book value stood at $521 million ($9.47 per share), or $11.60 per share excluding CECL reserve.
Outlook and guidance
Focused on resolving non-accrual and risk-rated 4 and 5 loans (~$170 million carrying value) and redeploying capital to expand the loan portfolio.
Targeting a return to portfolio growth in the first half of 2026.
Management anticipates additional repayments will further increase liquidity and support more investment activity.
The board extended the $50 million stock repurchase program through July 2026.
Primary sources of cash expected to be sufficient for operating and investing activities for at least the next 12 months.
Latest events from Ares Commercial Real Estate
- Q4 2025 saw a $3.9M net loss, reduced office exposure, and strong liquidity for a 12% yield.ACRE
Q4 202510 Feb 2026 - Q2 2024 net loss of $6.1M, high CECL reserves, and a $0.25 dividend declared.ACRE
Q2 20242 Feb 2026 - Q3 net loss of $5.9M, risk loan reduction, and $0.25 dividend declared.ACRE
Q3 202415 Jan 2026 - Net loss in 2024, but leverage, liquidity, and risk exposure improved.ACRE
Q4 20245 Jan 2026 - Annual meeting to vote on directors, auditor, executive pay, and governance policies.ACRE
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and say-on-pay at the 2025 meeting.ACRE
Proxy Filing1 Dec 2025 - Net loss of $11M, $33M loan loss, but liquidity and new loan activity improved.ACRE
Q2 202523 Nov 2025 - Q1 2025 net income was $9.3M, liquidity improved, and a $0.15 dividend was declared.ACRE
Q1 202521 Nov 2025